Xylanse variants having altered sensitivity to xylanse inhibitors
The present invention relates to a variant xylanase polypeptide, or fragment thereof having xylanase activity, comprising one or more amino acid modifications such that the polypeptide or fragment thereof has an altered sensitivity to a xylanase inhibitor as compared with the parent enzyme.
1. An isolated variant polypeptide or fragment thereof having at least 80% homology to SEQ ID NO: 1 as determined by using the GCG Wisconsin Bestfit package, and having xylanase activity, comprising two or more amino acid modifications, wherein said amino acid modifications are at two or more of positions 11, 12, 13, 15, 17, 29, 31, 32, 34, 113, 114, 119, 120, 121, 122, 123, 124 and 175 of the B. subtilis amino acid sequence shown as SEQ ID NO: 1, or their equivalent positions in other family 11 xylanases, such that the polypeptide or fragment thereof has altered sensitivity to a xylanase inhibitor as compared with the parent xylanase, wherein one of said modifications is at position 11, wherein the variant polypeptide is a family 11 xylanase, wherein said inhibitor is an inhibitor found naturally in wheat extract wherein said amino acid modifications are any of: D11Y, D11N, D11F, D11K, D11S, D11W, G12F, G13F, I15K, N17K, N17Y, N17D, N29K, N29Y, N29D, S31K, S31Y, S31D, N32K, G34D, G34F, G34T, Y113A, Y113D, Y113K, N114A, N114D, N114F, N114K, D119K, D119Y, D119N, G120K, G120D, G120F, G120Y, G120N, D121N, D121K, D121F, D121A, R122D, R122F, R122A, T123K, T123Y, T123D, T124K, T124Y, T124D, Q175E, Q175S and Q175L.
2. An isolated variant polypeptide according to claim 1 wherein the sensitivity of the variant polypeptide is reduced as compared to the parent xylanase enzyme.
3. A composition comprising an isolated variant polypeptide according to claim 1 .
4. An isolated variant polypeptide according to claim 1 , wherein two of said amino acid modifications are D11F and R122D.
5. An isolated variant polypeptide or fragment thereof having at least 80% homology to SEQ ID NO: 1 as determined by using the GCG Wisconsin Bestfit package, xylanase activity, comprising two or more amino acid modifications, wherein said amino acid modifications are at two or more of positions 11, 12, 13, 15, 17, 29, 31, 32, 34, 113, 114, 119, 120, 121, 122, 123, 124 and 175 of the B. subtilis amino acid sequence shown as SEQ ID NO: 1, such that the polypeptide or fragment thereof has altered sensitivity to a xylanase inhibitor found naturally in wheat plant tissues as compared with the parent xylanase, wherein one of said modifications is at position 11 and wherein the variant polypeptide is a family 11 xylanase.
6. An isolated variant polypeptide according to claim 5 , wherein one of said amino acid modifications is D11Y, D11N, D11F, D11K, D11S or D11W.
7. The isolated variant polypeptide according to claim 6 , wherein one of said amino acid modifications is D11F.